Gerresheimer (ETR:GXI) has been assigned a €81.00 ($94.19) target price by equities researchers at Berenberg Bank in a research note issued on Thursday. The firm presently has a “buy” rating on the stock. Berenberg Bank’s target price suggests a potential upside of 31.71% from the stock’s previous close.

Other equities research analysts have also issued reports about the stock. Deutsche Bank set a €77.00 ($89.53) price target on shares of Gerresheimer and gave the company a “buy” rating in a research note on Tuesday, June 19th. DZ Bank reiterated a “buy” rating on shares of Gerresheimer in a research note on Thursday, July 12th. Credit Suisse Group set a €72.00 ($83.72) price target on shares of Gerresheimer and gave the company a “buy” rating in a research note on Monday, July 9th. Independent Research set a €77.00 ($89.53) price target on shares of Gerresheimer and gave the company a “neutral” rating in a research note on Thursday, July 12th. Finally, equinet set a €69.00 ($80.23) price target on shares of Gerresheimer and gave the company a “neutral” rating in a research note on Thursday, July 12th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of €71.67 ($83.33).

Shares of GXI stock opened at €61.50 ($71.51) on Thursday. Gerresheimer has a 1 year low of €59.97 ($69.73) and a 1 year high of €78.25 ($90.99).

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Featured Story: What is a put option?

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.